Allworth Financial’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.6K Buy
845
+541
+178% +$22.7K ﹤0.01% 2494
2026
Q1
$9.79K Buy
304
+251
+474% +$9.29K ﹤0.01% 3523
2025
Q4
$2.23K Buy
53
+17
+47% +$685 ﹤0.01% 4081
2025
Q3
$1.24K Sell
36
-428
-92% -$12.3K ﹤0.01% 4187
2025
Q2
$12.5K Buy
464
+394
+563% +$11.4K ﹤0.01% 2784
2025
Q1
$2.25K Buy
70
+37
+112% +$1.41K ﹤0.01% 3166
2024
Q4
$1.42K Buy
+33
New +$1.25K ﹤0.01% 3284
2024
Q3
– Sell
-146
Closed -$3.38K – 3841
2024
Q2
$3.38K Buy
146
+129
+759% +$2.71K ﹤0.01% 2692
2024
Q1
$377 Sell
17
-75
-82% -$1.83K ﹤0.01% 3360
2023
Q4
$2.53K Buy
92
+87
+1,740% +$2.1K ﹤0.01% 2573
2023
Q3
$112 Buy
+5
New +$129 ﹤0.01% 3339

Other funds holding VCYT

Allworth Financial's VCYT Position: Q2 2026 in Review

Allworth Financial increased its Veracyte (VCYT) stake by 178% in Q2 2026, buying an estimated $22.7K and bringing the position to 845 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Allworth Financial first reported a position in VCYT in Q3 2023 and has held it in 11 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Allworth Financial held 845 shares of Veracyte worth $49.6K as of Q2 2026.
  • Allworth Financial bought 541 Veracyte shares in Q2 2026, an estimated $22.7K.
  • Veracyte made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2494 holding.
  • Allworth Financial first reported a position in Veracyte in Q3 2023 and has held it in 11 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.